Coeptis Therapeutics’ Board Buys Surge: CEO Craig Purchases 9,868 RSUs, Hinting at Imminent Deal‑Making Flurry
Insider buying surge at Coeptis Therapeutics signals a likely merger or asset deal—investors should watch upcoming filings for the next strategic move.
- Coeptis Therapeutics Holdings Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read
